FY2026 Earnings
Financial report interval: 2025.03.31 - 2026.03.31
Overview: JACOBSON PHARMA(02633) the Revenue is 1.569 B (--%), Beat estimate;the EBIT is 388.65 M (--%), Beat estimate;the EPS is 0.151 (-0.33%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.57B--
1.55B--
+0.02B--%
EBITExceed expectations
0.39B--
0.34B--
+0.05B--%
EPSExceed expectations
0.1510.33%
0.1379.57%
+0.01409.24%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf